Efthymios Deliargyris - Net Worth and Insider Trading
Efthymios Deliargyris Net Worth
The estimated net worth of Efthymios Deliargyris is at least $306,621 dollars as of 2024-05-04. Efthymios Deliargyris is the Chief Medical Officer of CytoSorbents Corp and owns about 348,433 shares of CytoSorbents Corp (CTSO) stock worth over $306,621. Details can be seen in Efthymios Deliargyris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Efthymios Deliargyris has not made any transactions after 2023-12-13 and currently still holds the listed stock(s).
Transaction Summary of Efthymios Deliargyris
Efthymios Deliargyris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Efthymios Deliargyris owns 2 companies in total, including CytoSorbents Corp (CTSO) , and PLx Pharma Winddown Corp (PLXPQ) .
Click here to see the complete history of Efthymios Deliargyris’s form 4 insider trades.
Insider Ownership Summary of Efthymios Deliargyris
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTSO | CytoSorbents Corp | 2023-12-13 | Chief Medical Officer |
| PLXPQ | PLx Pharma Winddown Corp | 2018-08-29 | Chief Medical Officer |
Efthymios Deliargyris Latest Holdings Summary
Efthymios Deliargyris currently owns a total of 1 stock. Efthymios Deliargyris owns 348,433 shares of CytoSorbents Corp (CTSO) as of December 13, 2023, with a value of $306,621.
Latest Holdings of Efthymios Deliargyris
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTSO | CytoSorbents Corp | 2023-12-13 | 348,433 | 0.88 | 306,621 |
Holding Weightings of Efthymios Deliargyris
Efthymios Deliargyris Form 4 Trading Tracker
According to the SEC Form 4 filings, Efthymios Deliargyris has made a total of 1 transactions in CytoSorbents Corp (CTSO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CytoSorbents Corp is the acquisition of 22,557 shares on December 13, 2023, which cost Efthymios Deliargyris around $30,001.
Insider Trading History of Efthymios Deliargyris
- 1
Efthymios Deliargyris Trading Performance
GuruFocus tracks the stock performance after each of Efthymios Deliargyris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Efthymios Deliargyris is -42.29%. GuruFocus also compares Efthymios Deliargyris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Efthymios Deliargyris within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Efthymios Deliargyris's insider trading performs compared to the benchmark.
Performance of Efthymios Deliargyris
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.19 |  | | | | |
| Relative Return to S&P 500(%) | -44.82 | | | | | |
Efthymios Deliargyris Ownership Network
Efthymios Deliargyris Owned Company Details
What does CytoSorbents Corp do?
Who are the key executives at CytoSorbents Corp?
Efthymios Deliargyris is the Chief Medical Officer of CytoSorbents Corp. Other key executives at CytoSorbents Corp include Chief Financial Officer Kathleen P. Bloch , Chief Operating Officer Vincent Capponi , and director & President and CEO Phillip P. Chan .
CytoSorbents Corp (CTSO) Insider Trades Summary
Over the past 18 months, Efthymios Deliargyris made 1 insider transaction in CytoSorbents Corp (CTSO) with a net purchase of 22,557. Other recent insider transactions involving CytoSorbents Corp (CTSO) include a net purchase of 105,188 shares made by Phillip P. Chan , a net purchase of 50,894 shares made by Kathleen P. Bloch , and a net purchase of 40,594 shares made by Michael G. Bator .
In summary, during the past 3 months, insiders sold 0 shares of CytoSorbents Corp (CTSO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoSorbents Corp (CTSO) were sold and 275,625 shares were bought by its insiders, resulting in a net purchase of 275,625 shares.
CytoSorbents Corp (CTSO)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytoSorbents Corp Insider Transactions
Efthymios Deliargyris Mailing Address
Above is the net worth, insider trading, and ownership report for Efthymios Deliargyris. You might contact Efthymios Deliargyris via mailing address: C/o Plx Pharma,inc.8285 El Rio Street, Suite 210, Houston Tx 77054.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
